CUH

Latest news

 

Efficient patient recruitment for innovative clinical trials of existing drugs to other indications – EU open day

The PONTE EU Open Day at CUH is to be held at the William Harvey Lecture Theatre on 31 January 2012


Public involvement in research group

Get involved in the design of future health and social care research at the launch of new group on 2 November 2011.


£110 million health research fund confirms elite biomedical status for CUH

Cambridge University Hospitals and the University of Cambridge have been awarded a record share of an £800 million government research fund, confirming the city’s status as one of the country’s elite Biomedical Research Centres.


Are you designing a study and do you need help with statistics?

The Centre for Applied Medical Statistics (CAMS) is a group of medical statisticians engaged in collaborative research and teaching.

> R&D news index

 

 

 

 

“Genetic screens in embryonic stem cells”

NIHR Cambridge Biomedical Research Centre Lecture Series 2009/10

When: Thursday 10 June 2010 – 5.00 pm

Drink reception follows at 6pm - open to all attendees

 

Where: CRUK Cambridge Research Institute Lecture Theatre
(Li Ka Shing Centre - Robinson Way)

 

Clinical Fellows

 

Guest lecturer: Professor Allan Bradley

 

Title of talk: “Genetic screens in embryonic stem cells”

 

 

Allan Bradley received his BA, MA & PhD in Genetics from University of Cambridge. His Ph.D. studies in Martin Evans laboratory laid the foundation for making knockout mice. In 1984 Allan Bradley and Liz Robertson demonstrated that embryonic stem (ES) cells could be transmitted through the germ line of mice and two years later reported that ES cells could be used to generate mice with mutations in endogenous genes.


In 1987, Allan took up an appointment as an Assistant Professor at Baylor College of Medicine, Houston Texas. He was appointed a Howard Hughes Medical Institute Investigator in 1993 and was promoted to full Professor in 1994. At Baylor, his laboratory developed the techniques, technology and tools for genetic manipulation in the mouse. This work has provided key functional information on many genes with an emphasis on cancer, DNA repair and embryonic development.


In 2000, Allan returned to the United Kingdom as Director of the Wellcome Trust Sanger Institute. In 2002 Allan Bradley was honoured by election to the Royal Society. Although he holds a senior administrative position, he still finds time to run an active research group of students and fellows who continue to develop tools and technologies for new mouse genetics as well as to explore gene function on a large scale.

 

 

Invitation letter to the lecture

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Back to top

 

 

 

For further details, please contact:

Sylvie Robinson

 

Tel: 01223 348490


sylvie.robinson@
addenbrookes.nhs.uk